~~<i id='B97A8DD713'><strike id='B97A8DD713'><tt id='B97A8DD713'><pre id='B97A8DD713'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：explore 2025-09-06 02:13:29 - browse：2

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： New company forms to vet health AI models, root out weaknesses

focus

knowledge

explore

focus

Wikipedia

entertainment

MariaFabrizioforSTAT“Issheinpain?”Iaskedquietlyasthepearlescentbaby-shapedimageonthescreenfoldeditsl

WSS

Organ transplantation is at a crossroads. Major reform is needed

Tuesday set an unofficial record for the hottest day on Earth. Wednesday may break it.

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Pharma needs to include young adults in clinical research

How artificial intelligence is being used to detect, treat cancer

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

hotspot

leisure time

focus

Bright Health sells Medicare Advantage business to Molina

Jailed Russian opposition leader Alexey Navalny gets 19 more years in prison

United colonoscopy coverage change 'may cost lives,' doctors say

Medical schools are missing the mark on artificial intelligence

At least 13 dead in Texas as scorching temps continue

Rock icon Freddie Mercury pre

The cancer drug shortage isn’t new — and neither are the solutions

Does Medicare's free annual wellness visit do any good?

Drug repurposing or repositioning? The language matters

Medical schools are missing the mark on artificial intelligence

knowledge

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

Taylor Swift shares sweet moment with Kobe Bryant's daughter Bianka at Eras Tour concert

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Scientists find bacteria from stomach of ancient iceman

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

explore

focus

Wikipedia

entertainment